Zura Bio Ltd - Warrants (20/03/2028) Overview
Get informed when a big investor buys or sells
+ Follow-68.80%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for ZURAW is -68.8%. That is below the sector sector average of 11.67%. Investors often review this figure alongside Zura Bio Ltd - Warrants (20/03/2028)'s historical trend and sector peers before judging valuation or financial health.
Against its sector companies, ZURAW currently prints -68.8% for ROE, while the sector average sits near 11.67%. That is roughly 689.8% below the sector mean. Large gaps often invite a closer look at Zura Bio Ltd - Warrants (20/03/2028)'s growth, margins, and balance sheet.
Return on Equity shows how effectively Zura Bio Ltd - Warrants (20/03/2028) converts resources into returns. At -68.8%, ZURAW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ZURAW's ROE (-68.8%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
